After months of tension between Washington and Big Pharma, President Donald Trump has signed a new executive order that could ...

Furthermore, Novo Nordisk should earn important label expansions for some of its current medicines while developing new ones in other areas. Semaglutide is being tested in Alzheimer's disease. And the ...